Table 1.
Control | Chronic pancreatitis | Statistical significance | |
No. of patients | 21 | 35 | |
Age (yr) | 34 ± 13 | 50 ± 10 | < 0.01 |
Body weight (kg) | 76 ± 4 | 64 ± 10 | < 0.01 |
Body mass index (kg/m2) | 25 ± 2.7 | 22 ± 3.4 | < 0.01 |
Serum total protein (g/L) | 76 ± 4 | 72 ± 8 | < 0.05 |
Serum albumin (g/L) | 46 ± 3.6 | 42 ± 8 | < 0.05 |
Serum triacylglycerol (mg/dL) | 107 ± 30 | 119 ± 43 | NS |
Serum cholesterol (mg/dL) | 195 ± 26 | 175 ± 44 | < 0.05 |
Glucose (mmol/L) | 5 ± 0.64 | 7.7 ± 2.8 | < 0.01 |
Insulin (μU/mL) | 12 ± 5.2 | 9.1 ± 4.4 | < 0.05 |
Homeostasis model assessment | 2.7 ± 1.3 | 2.6 ± 1.6 | NS |
Leptin (ng/mL) | 6.6 ± 2.9 | 3.9 ± 2.5 | < 0.01 |
Hemoglobin (mg/dL) | 15 ± 2.9 | 13 ± 1.8 | < 0.01 |
Blood urea nitrogen (mg/dL) | 11 ± 2.8 | 14 ± 6 | NS |
Creatinine (mg/dL) | 0.9 ± 0.13 | 0.89 ± 0.22 | NS |
Serum amylase (U/L) | 54 ± 31 | 65 ± 35 | NS |
Urine amylase (U/L) | 174 ± 66 | 344 ± 336 | < 0.05 |
Serum lipase (U/L) | 28 ± 16 | 69 ± 75 | < 0.05 |
Serum alanine aminotransferase (U/L) | 21 ± 9 | 38 ± 38 | < 0.05 |
Serum aspartate aminotransferase (U/L) | 19 ± 5 | 41 ± 45 | < 0.05 |
Serum alkaline phosphatase (U/L) | 80 ± 28 | 104 ± 65 | NS |
Serum-glutamyl transpeptidase (U/L) | 26 ± 14 | 112 ± 152 | < 0.05 |
NS: Not significant.